摘要
背景:分枝杆菌属导致结核病和麻风病等致命疾病。属于此属的细菌细胞壁在许多方面是独特的。它在宿主内的发病机制和细胞内存活中起主要作用。在细胞内病原体中,其细胞壁作为分子屏障并与宿主细胞环境相互作用以调节宿主防御反应。 目的:在这篇综述中,我们总结了参与独特分枝杆菌细胞壁生物合成的因素,了解它们作为药物靶点的潜力以及最近被评估为可能的药物靶点的发展。 结果:在细胞壁成分如抗原85复合物,糖基转移酶(GTs),LM(脂甘露聚糖)和LAM(脂阿拉伯甘露聚糖),mAGP复合物,脂肪分解酶的合成中发挥关键作用的几种细胞壁相关因子已被明确记录。大多数目前使用的抗TB方案中断了细胞壁合成,但是耐药菌株的出现使其必须识别新的药物靶标。已经在全世界范围内对抑制细胞壁成分合成的新型候选药物进行了深入的研究。 结论:研究表明细胞壁成分在其在分枝杆菌发病机制中的贡献是独特的。针对这些可以妨碍结核分枝杆菌的生长。在这项研究中,我们仔细审查了试验中的药物,并通过计算机发现筛选出潜在的候选药物。
关键词: 细胞壁,发病机理,抗TB方案,结核分枝杆菌,药物设计,药物发现。
图形摘要
Current Drug Targets
Title:Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design
Volume: 18 Issue: 16
关键词: 细胞壁,发病机理,抗TB方案,结核分枝杆菌,药物设计,药物发现。
摘要: Background: Mycobacteria genus is responsible for deadly diseases like tuberculosis and leprosy. Cell wall of bacteria belonging to this genus is unique in many ways. It plays a major role in the pathogenesis and intracellular survival inside the host. In intracellular pathogens, their cell wall acts as molecular shield and interacts with host cell milieu to modulate host defense responses.
Objectives: In this review, we summarize the factors that participate in the biosynthesis of unique mycobacterial cell wall, understand their potential as drug targets and the recent developments where they have been evaluated as possible drug targets.
Results: Several cell wall associated factors that play crucial roles in the synthesis of cell wall components like Antigen 85 complex, Glycosyltransferases (GTs), LM (lipomannan) and LAM (lipoarabinomannan), mAGP Complex, lipolytic enzyme have been categorically documented. Most of the presently used anti TB regimens interrupted cell wall synthesis, but the emergence of drug resistant strains made it mandatory to identify new drug targets. Novel drug candidates which could inhibit the synthesis of cell wall components have been thoroughly studied worldwide.
Conclusion: Studies demonstrated that the cell wall components are unique in terms of their contribution in mycobacterium pathogenesis. Targeting these can hamper the growth of M. tuberculosis. In this study, we scrutinize the drugs under trials and the potential candidates screened through in silico findings.
Export Options
About this article
Cite this article as:
Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design, Current Drug Targets 2017; 18 (16) . https://dx.doi.org/10.2174/1389450118666170711150034
DOI https://dx.doi.org/10.2174/1389450118666170711150034 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
iMTBGO: An Algorithm for Integrating Metabolic Networks with Transcriptomes Based on Gene Ontology Analysis
Current Genomics Editorial (Thematic Issue: Enzymatic Studies in Medicinal Chemistry of Neglected Diseases)
Current Protein & Peptide Science Developments in Structural Genomics: Protein Purification and Function Interpretation
Current Genomics Pentapeptides as Minimal Functional Units in Cell Biology and Immunology
Current Protein & Peptide Science Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients
Current HIV Research Computational Methods for Protein-Protein Interaction and their Application
Current Protein & Peptide Science A Computational Molecular Docking Studies on the Tryparedoxin Peroxidase of <i>Leishmania donovani</i> Responsible for Visceral Leishmaniasis in Human
Letters in Drug Design & Discovery Comparative Proteome Analysis of <i>Mycobacterium Tuberculosis</i> Strains - H37Ra, H37Rv, CCDC5180, and CAS/NITR204: A Step Forward to Identify Novel Drug Targets
Letters in Drug Design & Discovery Metabolic Imaging through Continuous In Situ Micro-extractions of Tissue Samples via Flowprobe Mass Spectrometry
Current Metabolomics Green Synthesis of Gold Nanoparticles Using Different Leaf Extracts of Ocimum gratissimum Linn for Anti-tubercular Activity
Current Nanomedicine Dendrimers and Dendritic Polymers as Anti-infective Agents: New Antimicrobial Strategies for Therapeutic Drugs
Anti-Infective Agents in Medicinal Chemistry Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery Gene Cloning and Homology Modeling of the 3-Oxoacyl-ACP Synthase from Aeromonas hydrophila for Drug Discovery
Letters in Drug Design & Discovery Conjugated Diyne Chemistry: Synthesis, Natural Existence and Applications
Current Organocatalysis Evaluation of Small Molecule Tuberculostats for Targeting Tuberculosis Infections of the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal Macrophagic Myofasciitis and ASIA
Current Medicinal Chemistry Chemical Constituents and Biological Activities of Cordia myxa L.: A Review
The Natural Products Journal Design, Synthesis, Characterization and Antitubercular Screening of some New 1,2,4-Triazoles Derived from Isonicotinic Acid Hydrazides
Letters in Drug Design & Discovery Multi-Target Antitubercular Drugs
Current Topics in Medicinal Chemistry Growing Burden of Diabetes in Sub- Saharan Africa: Contribution of Pesticides ?
Current Diabetes Reviews